nipple reconstruction

TeVido BioDevices Receives National Institutes of Health Phase I SBIR Grant

The award furthers research on 3D bioprinting of nipple areola complex for reconstruction in breast cancer survivors. TeVido BioDevices, an early stage 3D bioprinting company creating natural human grafts for reconstructive procedures announced today that they have been awarded a Small Business Innovation Research (SBIR) Grant from the National Cancer Institute of the National Institutes Read more about TeVido BioDevices Receives National Institutes of Health Phase I SBIR Grant[…]

TeVido BioDevices Receives Phase II SBIR Grant from National Science Foundation for Breast Reconstruction using 3D Bioprinting

The NSF SBIR Phase II grant validates approach for novel treatments that provide benefit to breast cancer survivors. BioDevices, an early stage 3D bioprinting company creating natural human grafts for reconstructive procedures, announced today, Breast Reconstruction Awareness (BRA) Day, receipt of a Small Business Innovation Research (SBIR) Phase II Grant from the National Science Foundation (NSF) Read more about TeVido BioDevices Receives Phase II SBIR Grant from National Science Foundation for Breast Reconstruction using 3D Bioprinting[…]

nipple reconstruction

TeVido BioDevices a finalist in LIVESTRONG Foundation’s Big C Competition

TeVido BioDevices, developer of 3D bioprinted grafts for use in breast reconstruction, was announced as one of 5 finalists out of 750+ global entries. The global social innovation challenge began on World Cancer Day with more than 750 individuals and groups entering a project that aimed to solve daily issues faced by people affected by cancer Read more about TeVido BioDevices a finalist in LIVESTRONG Foundation’s Big C Competition[…]

nipple reconstruction

TeVido BioDevices Named to Venture Accelerator Phase of LIVESTRONG Foundation’s Big C Competition

TeVido BioDevices was selected as one of 20 entries to move on to the Entrepreneur Accelerator Program phase of the LIVESTRONG Foundation’s Big C competition, aiming to change the way the world lives with cancer. TeVido BioDevices will now be vying for one of five spots in the contest’s final round, competing to win $25,000. The Read more about TeVido BioDevices Named to Venture Accelerator Phase of LIVESTRONG Foundation’s Big C Competition[…]

2013 Regulatory Affairs Professional Society (RAPS) Global Conference: The Regulatory Convergence in Boston to Feature Harvard Health School Dean, Biomedical Innovators, FDA and Global Regulatory Officials

TeVido CEO, Laura Bosworth-Bucher  announced as Closing Keynote Presenter and Panelist. Technologies such as 3-D bio printing and mobile medical apps are challenging regulators to adapt existing regulatory frameworks to products that were barely imaginable only a few years ago. In the conference’s closing plenary on Wednesday, 2 October, entitled “Medical Innovation: The Future is Read more about 2013 Regulatory Affairs Professional Society (RAPS) Global Conference: The Regulatory Convergence in Boston to Feature Harvard Health School Dean, Biomedical Innovators, FDA and Global Regulatory Officials[…]

TeVido receives National Science Foundation Small Business Innovation Research (SBIR) Grant

National Science Foundation Awards Tevido BioDevices has been awarded a Phase I NSF grant.  The Small Business Innovation Research (SBIR) program is a highly competitive program that encourages  small businesses to engage in Research and Development.  SBIR enables small businesses to explore their technological potential and provides the incentive to profit from its commercialization. The results Read more about TeVido receives National Science Foundation Small Business Innovation Research (SBIR) Grant[…]